34 publications

Name Date Type Actions

20145 calendar of financial communication

December 15, 2014 (Lure, France) – Vétoquinol published its calendar of financial communication for 2015.

 		15/12/2014 Agenda

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

 		03/01/2024 Agenda

2016 calendar of financial communication

December 15, 2015 (Lure, France) – Vétoquinol published its calendar of financial communication for 2016.

 		15/12/2015 Agenda

2021 calendar of financial communication

December 15, 2020 (Lure, France) - Vetoquinol published its calendar of financial communication for 2021.

 		15/12/2020 Agenda

2022 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2022.

 		17/12/2021 Agenda

Financial report 2007

Consolidated 2007 figures are even better than the targets in the business plan we presented for the initial public offering (IPO) in November 2006.
<br>
Revenues rose by 10.3% to 233.4 million euros (211.6 million euros in 2006), including 7.6% organic growth.
<br>
The operating profit from continuing operations increased by 13.9%, from 25.6 million euros in 2006 to 29.2 million euros in 2007.
<br>
Finally, net profit increased by 17.8% to 18.6 million euros in 2007 (15.8 million euros in 2006), for a net margin of 8% (7.5% the previous year).

 		15/05/2008 Reference document

2008 financial report

Laboratoire pharmaceutique vétérinaire familial et indépendant, Vétoquinol se consacre exclusivement à la santé animale. Son activité est volontairement équilibrée entre animaux de rente et animaux de compagnie.
<br>
Historiquement implanté sur le marché français, le groupe réalise désormais 78% de son chiffre d'affaires consolidé à l'international (234,4 millions d'euros en 2008). Les 1400 collaborateurs du Groupe se répartissent entre la Recherche & Développement, la production et la commercilisation.
<br>
Aujourd'hui, la PME française -11e acteur mondial en santé animale (hors aliments)- produit et distribue 700 médicaments et produits non médicamenteux dans près de 100 pays (Europe, Amérique du Nord et Asie). Elle s'appuie sur ses filiales dans 22 pays et sur un réseau de 140 partenaires distributeurs.

 		04/05/2009 Reference document

Reference Document 2009

Reference Document 2009

 		23/04/2010 Reference document

Reference Document 2012 (in french)

Reference Document 2012 (in french)

 		16/04/2013 Reference document

Reference Document 2013

Reference Document 2013

 		14/04/2014 Reference document